CICCHIELLO, FEDERICA

CICCHIELLO, FEDERICA  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.013 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 02 - Intervento a convegno 2023 Gotuzzo, ICazzaniga, MDe Bernardi, ECicchiello, FCordani, NCerrito, MTurolla, ELandoni, CCrivellaro, CVirdone, LMonaco, LGuerra, L +
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 01 - Articolo su rivista 2022 Cicchiello F.Cordani N.Cerrito M. G.Cazzaniga M. E. +
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 01 - Articolo su rivista 2022 Cazzaniga M. E.Baroni S.Cicchiello F.Cordani N.Cerrito M. G. +
Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study 01 - Articolo su rivista 2021 Galimberti, StefaniaLeone, Biagio EugenioPacifico, ClaudiaCicchiello, FedericaCazzaniga, Marina Elena +
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale 01 - Articolo su rivista 2021 Bani, MarcoRossi, EmanuelaCortinovis, DiegoRusso, SelenaCicchiello, FedericaCazzaniga, Marina ElenaBidoli, PaoloValsecchi, Maria GraziaStrepparava, Maria Grazia +
A possible biomarker for paclitaxel-induced peripheral neurotoxicity: Neurofilament light chain serum levels monitoring 02 - Intervento a convegno 2020 Alberti, PCicchiello, FCavaletti, GCazzaniga, ME +
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 02 - Intervento a convegno 2020 Alberti, PCicchiello, FRiva, FCazzaniga, ME
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 01 - Articolo su rivista 2019 Cazzaniga M. E.Cicchiello F. +